Acrux Ltd

ACR

Company Profile

  • Business description

    Acrux Ltd is a pharmaceutical company dedicated to developing and commercializing generic transdermal and topical prescription pharmaceuticals. The group is formulating and developing a range of topical generic products by leveraging its skilled workforce, on-site laboratories, GMP manufacturing suite, and technical, clinical, and commercial experience to bring affordable products to market. Geographically, it has a presence in Australia; the United States; Europe, and other countries. The firm operates in a single segment and derives revenue from developing and commercializing pharmaceutical products that administer drugs topically. Its product pipeline includes Lenzetto, Evamist, Testosterone Topical Solution, and others.

  • Contact

    103-113 Stanley Street
    West Melbourne
    MelbourneVIC3003
    AUS

    T: +61 383790100

    E: [email protected]

    https://www.acrux.com.au

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    30 June 2026

    Employees

    36

Stocks News & Analysis

stocks

Apple earnings: Strong performance overpowers headwinds, and we raise our FVE

Our view of Apple shares.
stocks

Coles is winning the supermarket wars but is Woollies the better long-term opportunity?

Our view after first quarter sales updates.
stocks

Microsoft earnings: Strong, including Azure, but overall guidance is in line

We think Microsoft stock is moderately undervalued.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,182.5024.000.26%
CAC 408,109.7911.28-0.14%
DAX 4024,132.41174.110.73%
Dow JONES (US)47,358.68204.19-0.43%
FTSE 1009,701.3715.88-0.16%
HKSE26,158.36251.710.97%
NASDAQ23,855.36130.400.55%
Nikkei 22552,411.341,085.732.12%
NZX 50 Index13,556.307.980.06%
S&P 5006,856.4716.270.24%
S&P/ASX 2008,894.8036.200.41%
SSE Composite Index3,976.5221.730.55%

Market Movers